Entero Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Entero Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q1 2024.
  • Entero Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $181K, a 25.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $181K -$62.3K -25.6% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $195K -$63.8K -24.6% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $212K -$62.7K -22.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $228K -$61.6K -21.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $244K -$69.3K -22.1% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $259K -$76.9K -22.9% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $275K -$94K -25.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $290K -$106K -26.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $313K +$251K +409% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $336K +$262K +353% Dec 31, 2021 10-K 2023-03-20
Q3 2021 $369K +$264K +254% Sep 30, 2021 10-Q/A 2021-11-16
Q2 2021 $396K +$266K +205% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $61.5K +$8.13K +15.2% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 $74.2K -$8.15K -9.89% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $104K -$85.8K -45.2% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $130K -$112K -46.4% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $53.4K -$235K -81.5% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $82.4K +$82.4K Dec 31, 2019 10-K 2021-03-31
Q3 2019 $190K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $242K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $289K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.